FDA Approved: DAPTOMYCIN — Supplemental Application (APOTEX CORP.)

View source ↗

Summary

FDA approved a supplemental application for Daptomycin from Apotex Corp. (ANDA 215316).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Skin Structure Infections
• Right-sided Infective Endocarditis Due to Staphylococcus Aureus
• Staphylococcus Aureus Bacteremia

Drugs mentioned

• Daptomycin (daptomycin)

Snippet

SUPPL AP for DAPTOMYCIN (DAPTOMYCIN)